Rochester, MINNESOTA1 Active Studies

Antiphospholipid Syndrome Clinical Trials in Rochester, MINNESOTA

Find 1 actively recruiting antiphospholipid syndrome clinical trials in Rochester, MINNESOTA. Connect with local research sites and explore new treatment options.

1
Active Trials
1
Sponsors
22
Enrolling

Recruiting Antiphospholipid Syndrome Studies in Rochester

About Antiphospholipid Syndrome Clinical Trials in Rochester

Antiphospholipid syndrome is an autoimmune disorder that increases the risk of blood clots in arteries and veins, and pregnancy complications. It occurs when the immune system makes antibodies that attack phospholipids. Treatment primarily involves anticoagulant medications.

There are currently 1 antiphospholipid syndrome clinical trials recruiting participants in Rochester, MINNESOTA. These studies are seeking a combined 22 participants. Research is being sponsored by National Institute of Allergy and Infectious Diseases (NIAID). Clinical trial participation is free and participants receive study-related medical care at no cost.

Antiphospholipid Syndrome Clinical Trials in Rochester — FAQ

Are there antiphospholipid syndrome clinical trials in Rochester?

Yes, there are 1 antiphospholipid syndrome clinical trials currently recruiting in Rochester, MINNESOTA. Browse the studies on this page to find one that fits.

How do I join a clinical trial in Rochester?

Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Rochester research site will contact you about next steps.

Are clinical trials in Rochester free?

Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Rochester studies also compensate for your time and travel.

What antiphospholipid syndrome treatments are being tested?

The 1 active trials in Rochester are testing new therapies including novel drugs, biologics, and treatment approaches for antiphospholipid syndrome.

Data updated March 2, 2026 from ClinicalTrials.gov